Galmed Pharmaceuticals
GLMD
GLMD
31 hedge funds and large institutions have $34M invested in Galmed Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0.01% less ownership
Funds ownership: 0.17% → 0.15% (-0.01%)
Holders
31
Holding in Top 10
1
Calls
$3K
Puts
–
Top Buyers
| 1 | +$863K | |
| 2 | +$279K | |
| 3 | +$266K | |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$174K |
| 5 |
RCG
Rock Creek Group
Washington,
District of Columbia
|
+$170K |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$788K | |
| 3 | -$696K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$109K |
| 5 |
WAM
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
-$65K |